- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/18 - Growth factors; Growth regulators
Patent holdings for IPC class A61K 38/18
Total number of patents in this class: 5754
10-year publication summary
445
|
514
|
505
|
508
|
516
|
453
|
415
|
472
|
310
|
101
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
114 |
Regeneron Pharmaceuticals, Inc. | 3650 |
102 |
Acceleron Pharma Inc. | 365 |
90 |
Warsaw Orthopedic, Inc. | 3184 |
65 |
Amgen Inc. | 3779 |
63 |
Novartis AG | 11238 |
58 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
57 |
NGM Biopharmaceuticals, Inc. | 181 |
56 |
President and Fellows of Harvard College | 5792 |
50 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
46 |
Modernatx, Inc. | 1181 |
40 |
New York University | 1635 |
40 |
The General Hospital Corporation | 4517 |
39 |
Translate bio, Inc. | 394 |
39 |
The Trustees of the University of Pennsylvania | 4122 |
36 |
The Salk Institute for Biological Studies | 436 |
33 |
The Brigham and Women's Hospital, Inc. | 2087 |
29 |
Bristol-myers Squibb Company | 5080 |
28 |
Zensun (Shanghai) Science & Technology, Co., Ltd. | 53 |
28 |
Merck Patent GmbH | 5909 |
27 |
Other owners | 4714 |